Skip to main content
. 2021 Nov 27;7(1):100350. doi: 10.1016/j.esmoop.2021.100350

Figure 2.

Figure 2

Biological therapies and antibody responses after either dose of mRNA-BNT162b2 vaccine.

(A) Comparison of distributions and medians of logarithmic IgG titer between treatment subgroups and control at timepoint-2. (B) Comparison of distributions and medians of logarithmic IgG titer between treatment subgroups and control at timepoint-3.

Bars represent median values with 95% confidence interval.

AU, arbitrary units; CDK, cyclin-dependent kinase; IgG, immunoglobulin G; mTOR, mechanistic target of rapamycin; PARP, poly (ADP-ribose) polymerase; RBD-S1, receptor binding domain of the S1 subunit of the SARS-CoV-2 spike protein; TKIs, tyrosine kinase inhibitors.